Year: 2026
Type: article
Abstract: Protein tyrosine phosphorylation is a critical regulator of podocyte function, controlling cell adhesion, signaling, and cytoskeletal architecture. The receptor-type protein tyrosine phosphatase PTPRO (GLEPP1) is highly expressed in podocytes, and its dysregulation contributes to podocytopathies. However, the mechanisms controlling PTPRO expression under stress remain incompletely understood. Here, we demonstrate that PTPRO is expressed in conditionally immortalized human podocytes and is dynamically regulated. Exposure to the pro-fibrotic cytokine TGF-β induced an upregulation of PTPRO, accompanied by a concomitant downregulation of microRNA-26b (miR-26b), which we identified as a post-transcriptional regulator of PTPRO. Furthermore, the podocyte stressor puromycin aminonucleoside markedly suppressed PTPRO expression, whereas glucocorticoids induced PTPRO, highlighting context-dependent regulation. These results reveal a novel TGF-β/miR-26b/PTPRO signaling axis that modulates podocyte cytoskeletal integrity and underscores the complexity of targeting phosphatase pathways therapeutically in proteinuric kidney diseases, including both steroid-sensitive and steroid-resistant forms.
Source: PLoS ONE
Authors: Nina Sopel(Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Validation, Visualization, Writing – review & editing), Carmen Popanda(Data curation, Formal analysis, Methodology, Visualization, Writing – review & editing), Alexandra Ohs(Data curation, Methodology), Janina Müller-Deile(Conceptualization, Formal analysis, Funding acquisition, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: PTPRO, podocytes, protein tyrosine phosphatase, TGF-beta, microRNA-26b, post-transcriptional regulation, glucocorticoids, puromycin aminonucleoside, cytoskeletal integrity, proteinuria, podocytopathy, renal fibrosis, steroid-sensitive nephrotic syndrome, steroid-resistant nephrotic syndrome
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W7234014292
